Literature DB >> 22856512

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

S Fournier1, F Brossier, N Fortineau, F Gillaizeau, A Akpabie, A Aubry, F Barbut, F X Chedhomme, N Kassis-Chikhani, J C Lucet, J Robert, D Seytre, I Simon, D Vanjak, J R Zahar, C Brun-Buisson, V Jarlier.   

Abstract

Repeated outbreaks of vancomycin-resistant Enterococcus faecium (VRE) occurred between 2004 and 2010 in Assistance Publique--Hôpitaux de Paris (AP-HP), a 23,000-bed multi-hospital institution. From August 2004 to December 2005, the French guidelines for preventing cross-transmission of multiresistant bacteria were applied. Because the number of VRE cases continued to increase, an institutional control programme was implemented from January 2006 onwards: it foresees stopping transfer of VRE and contact patients, separating VRE and contact patients in distinct cohorts, intervention of a central infection control team to support local teams, and quick application of measures as soon as first VRE cases are identified. Between August 2004 and December 2010, 45 VRE outbreaks occurred in 21 of the 38 AP-HP hospitals, comprising 533 cases. Time series analysis showed that the mean number of cases increased by 0.8 cases per month (95% confidence interval (CI): 0.3 to 1.3, p=0.001) before, and decreased by 0.7 cases per month after implementation of the programme (95% CI: -0.9 to -0.5, p<0.001), resulting in a significant trend change of -1.5 cases per month (95% CI: -2.1 to -0.9, p<0.001). The number of cases per outbreak was significantly lower after implementation of the programme. A sustained and coordinated strategy can control emerging bacteria at the level of a large regional multihospital institution.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856512

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  9 in total

1.  The complex dynamics of antimicrobial activity in the human gastrointestinal tract.

Authors:  Louis B Rice
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

2.  Expansion of Vancomycin-Resistant Enterococcus faecium in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation.

Authors:  Jan Liese; Leonard Schüle; Philipp Oberhettinger; Leonie Tschörner; Tran Nguyen; Daniela Dörfel; Wichard Vogel; Matthias Marschal; Ingo Autenrieth; Matthias Willmann; Silke Peter
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 3.  Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.

Authors:  Nico T Mutters; Volker Mersch-Sundermann; Reinier Mutters; Christian Brandt; Wulf Schneider-Brachert; Uwe Frank
Journal:  Dtsch Arztebl Int       Date:  2013-10-25       Impact factor: 5.594

4.  Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.

Authors:  D Lepelletier; J C Lucet; P Astagneau; B Coignard; S Vaux; C Rabaud; B Grandbastien; P Berthelot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-10       Impact factor: 3.267

5.  Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan.

Authors:  Norihiro Saito; Junichi Kitazawa; Hiroko Horiuchi; Takeo Yamamoto; Masahiko Kimura; Fumio Inoue; Mika Matsui; Satoko Minakawa; Masamichi Itoga; Junichiro Tsuchiya; Satowa Suzuki; Junzo Hisatsune; Yoshiaki Gu; Motoyuki Sugai; Hiroyuki Kayaba
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-23       Impact factor: 6.454

6.  Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.

Authors:  Gabriel Birgand; Raymond Ruimy; Michael Schwarzinger; Isabelle Lolom; Gisèle Bendjelloul; Nadira Houhou; Laurence Armand-Lefevre; Antoine Andremont; Yazdan Yazdanpanah; Jean-Christophe Lucet
Journal:  Antimicrob Resist Infect Control       Date:  2013-11-04       Impact factor: 4.887

7.  Patient safety work in Sweden: quantitative and qualitative analysis of annual patient safety reports.

Authors:  Mikaela Ridelberg; Kerstin Roback; Per Nilsen; Siw Carlfjord
Journal:  BMC Health Serv Res       Date:  2016-03-21       Impact factor: 2.655

8.  Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.

Authors:  Gabriel Birgand; Christophe Leroy; Simone Nerome; Liem Binh Luong Nguyen; Isabelle Lolom; Laurence Armand-Lefevre; Céline Ciotti; Bertrand Lecorre; Géraldine Marcade; Vincent Fihman; Marie-Hélène Nicolas-Chanoine; Camille Pelat; Anne Perozziello; Bruno Fantin; Yazdan Yazdanpanah; Jean-Damien Ricard; Jean-Christophe Lucet
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

9.  Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.

Authors:  Sandra Fournier; Laure Desenfant; Catherine Monteil; Michèle Nion-Huang; Christian Richard; Vincent Jarlier
Journal:  Euro Surveill       Date:  2018-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.